Plus Therapeutics
PSTV3.6303.46% ( -0.130 )
Forecast & Rating4 analysts currently cover Plus Therapeutics, of which 4 give a positive rating. The average price target is $36.00, about 891.7% upside from the current price of $3.63. Coverage is limited, so the data is for reference only. Data as of Jul 1, 2026; this does not constitute investment advice.
Jul 1, 2026Price forecast
$36.00891.74%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 26, 2026
Forecast met2.3%
Stock price$3.63
Average forecast price$36.0
Highest forecast price$57
Lowest forecast price$12
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.